What is NDC 13668-676?

13668-676 is the product NDC for Dichlorphenamide, Dichlorphenamide 50 mg/1 tablet, listed with the FDA by Torrent pharmaceuticals limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Torrent pharmaceuticals limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dichlorphenamide?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dichlorphenamide NDC 13668-676 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)13668-676Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13668-0676Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
13668-676-01	1366806760113668067601	100 TABLET in 1 BOTTLE (13668-676-01)Marketed from Dec 29, 2022
13668-676-30	1366806763013668067630	30 TABLET in 1 BOTTLE (13668-676-30)Marketed from Dec 29, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dichlorphenamide
Generic name (nonproprietary): dichlorphenamide
Active ingredients: Dichlorphenamide — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Torrent pharmaceuticals limitedNDC labeler code 13668
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215924
Marketing start: Dec 29, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 13668-676_1d0520f1-bf08-4def-a715-2ab45a18393eSPL ID 1d0520f1-bf08-4def-a715-2ab45a18393eSPL set ID 64bf0c71-2113-47dc-8ce5-7fe535e558dcRxCUI 197594UNII VVJ6673MHYUPC 0313668676303
Pharmacologic class: Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413668067601 followed by a unit qualifier and the quantity

Package 13668-0676-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 5, 2026.

Indications (excerpt from the label)

Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. Dichlorphenamide tablets are an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 13668-676

What is NDC 13668-676?: 13668-676 is the product NDC for Dichlorphenamide, Dichlorphenamide 50 mg/1 tablet, listed with the FDA by Torrent pharmaceuticals limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dichlorphenamide.
What is the active ingredient?: Dichlorphenamide.
Who is the labeler?: Torrent pharmaceuticals limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dichlorphenamide?: 1 other product NDC are listed under this name. See all Dichlorphenamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dichlorphenamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dichlorphenamide	Dichlorphenamide 50 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-242	16571-0242-01

Other NDCs under ANDA 215924

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215924
Product	Strength	Form · route	Labeler	Product NDC
Ormalvidichlorphenamide	Dichlorphenamide 50 mg/1	TabletOral	Cycle Pharmaceuticals Ltd.	70709-085